Particulars | This Scheme | Category |
---|---|---|
No. of Stocks | 45 | 76.76 |
Top 5 Stock Weight | 33.67% | 37.13% |
Top 10 Stock Weight | 54.28% | 54.07% |
Top 3 Sector Weight | 98.99% | 34.16% |
Particulars | This Scheme | Category |
---|---|---|
Average mcap (Cr) | 21609.24 | 112660.19 |
Holdings in large cap stocks | 26.91% | 51.18% |
Holdings in mid cap stocks | 16.59% | 15.66% |
Holdings in small cap stocks | 1.63% | 8.34% |
Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
---|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 177.2 | 10.89% | 0.05% | 13.34% (Oct 2024) | 10.84% (Aug 2025) | 1.11 L | 73.00 |
Max Healthcare Institute Ltd. | Hospital | 100.4 | 6.17% | -0.19% | 7.08% (Jun 2025) | 5.85% (Nov 2024) | 90.06 k | 59.00 |
Cipla Ltd. | Pharmaceuticals | 98.4 | 6.05% | -0.31% | 6.36% (Aug 2025) | 5.7% (Dec 2024) | 65.48 k | 54.00 |
Apollo Hospitals Enterprises Ltd. | Hospital | 86.4 | 5.31% | -0.12% | 5.43% (Aug 2025) | 4.75% (Feb 2025) | 11.66 k | 8.00 |
ELI LILLY ORD SHS | Foreign equity | 85.4 | 5.25% | 0.24% | 6.34% (Feb 2025) | 4.86% (May 2025) | 1.26 k | -12.00 |
Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 82.8 | 5.09% | -0.12% | 5.76% (Dec 2024) | 5.08% (Feb 2025) | 67.65 k | 52.00 |
Divis Laboratories Ltd. | Pharmaceuticals | 78.7 | 4.84% | -0.35% | 6.03% (May 2025) | 4.84% (Sep 2025) | 13.83 k | 9.00 |
Johnson & Johnson | Foreign equity | 61.9 | 3.80% | 0.18% | 3.8% (Sep 2025) | 2.84% (Dec 2024) | 3.76 k | -40.00 |
AbbVie Inc | Foreign equity | 56.8 | 3.49% | 0.33% | 3.49% (Sep 2025) | 2.49% (Nov 2024) | 2.76 k | -31.00 |
Fortis Healthcare Ltd. | Hospital | 55.1 | 3.39% | 0.22% | 3.39% (Sep 2025) | 2.3% (Oct 2024) | 56.83 k | 38.00 |
Stock Invested in |
Sector |
Sector Total |
Value(Mn) |
% of Total Holdings |
1M Change |
1Y Highest Holding |
1Y Lowest Holding |
Quantity |
1M Change in Qty |
M-Cap |
GroupName |
---|---|---|---|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 51.39 | 177.2 | 10.89% | 0.05% | 13.34% (Oct 2024) | 10.84% (Aug 2025) | 1.11 L | 73.00 | Large Cap | 26.91 |
Max Healthcare Institute Ltd. | Hospital | 16.5 | 100.4 | 6.17% | -0.19% | 7.08% (Jun 2025) | 5.85% (Nov 2024) | 90.06 k | 59.00 | Other | 54.66 |
Cipla Ltd. | Pharmaceuticals | 51.39 | 98.4 | 6.05% | -0.31% | 6.36% (Aug 2025) | 5.7% (Dec 2024) | 65.48 k | 54.00 | Large Cap | 26.91 |
Apollo Hospitals Enterprises Ltd. | Hospital | 16.5 | 86.4 | 5.31% | -0.12% | 5.43% (Aug 2025) | 4.75% (Feb 2025) | 11.66 k | 8.00 | Mid Cap | 16.59 |
ELI LILLY ORD SHS | Foreign equity | 31.1 | 85.4 | 5.25% | 0.24% | 6.34% (Feb 2025) | 4.86% (May 2025) | 1.26 k | -12.00 | Other | 54.66 |
Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 51.39 | 82.8 | 5.09% | -0.12% | 5.76% (Dec 2024) | 5.08% (Feb 2025) | 67.65 k | 52.00 | Other | 54.66 |
Divis Laboratories Ltd. | Pharmaceuticals | 51.39 | 78.7 | 4.84% | -0.35% | 6.03% (May 2025) | 4.84% (Sep 2025) | 13.83 k | 9.00 | Large Cap | 26.91 |
Johnson & Johnson | Foreign equity | 31.1 | 61.9 | 3.80% | 0.18% | 3.8% (Sep 2025) | 2.84% (Dec 2024) | 3.76 k | -40.00 | Other | 54.66 |
AbbVie Inc | Foreign equity | 31.1 | 56.8 | 3.49% | 0.33% | 3.49% (Sep 2025) | 2.49% (Nov 2024) | 2.76 k | -31.00 | Other | 54.66 |
Fortis Healthcare Ltd. | Hospital | 16.5 | 55.1 | 3.39% | 0.22% | 3.39% (Sep 2025) | 2.3% (Oct 2024) | 56.83 k | 38.00 | Other | 54.66 |
Lupin Ltd. | Pharmaceuticals | 51.39 | 50.5 | 3.11% | 0.05% | 3.82% (Dec 2024) | 3.06% (Aug 2025) | 26.44 k | 26.00 | Large Cap | 26.91 |
Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 51.39 | 49.4 | 3.04% | 0.05% | 3.1% (Jul 2025) | 2.42% (Dec 2024) | 13.72 k | 9.00 | Mid Cap | 16.59 |
Mankind Pharma Ltd. | Pharmaceuticals | 51.39 | 34.9 | 2.15% | -0.02% | 2.33% (May 2025) | 1.8% (Jan 2025) | 14.34 k | 15.00 | Other | 54.66 |
Laurus Labs Ltd. | Pharmaceuticals | 51.39 | 34.2 | 2.10% | -0.03% | 2.14% (Jul 2025) | 1.29% (Oct 2024) | 40.61 k | 51.00 | Other | 54.66 |
NOVARTIS AG | Foreign equity | 31.1 | 33.8 | 2.08% | 0.04% | 2.08% (Sep 2025) | 1.57% (Dec 2024) | 2.97 k | -27.00 | Other | 54.66 |
Aurobindo Pharma Ltd. | Pharmaceuticals | 51.39 | 32.8 | 2.02% | 0.12% | 2.77% (Oct 2024) | 1.9% (Aug 2025) | 30.27 k | 20.00 | Large Cap | 26.91 |
Abbott Laboratories | Foreign equity | 31.1 | 32.3 | 1.99% | 0.04% | 2.05% (Feb 2025) | 1.48% (Oct 2024) | 2.72 k | -16.00 | Other | 54.66 |
Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 51.39 | 31.9 | 1.96% | 0.04% | 2.1% (Jul 2025) | 1.41% (Feb 2025) | 16.34 k | 11.00 | Mid Cap | 16.59 |
Merck & Co Inc Shs | Foreign equity | 31.1 | 29.2 | 1.80% | 0.01% | 2.14% (Jan 2025) | 1.59% (May 2025) | 3.92 k | -44.00 | Other | 54.66 |
Zydus Lifesciences Ltd. | Pharmaceuticals | 51.39 | 28.6 | 1.76% | 0.01% | 1.89% (Oct 2024) | 1.66% (Apr 2025) | 29.13 k | 19.00 | Mid Cap | 16.59 |
Alkem Laboratories Ltd. | Pharmaceuticals | 51.39 | 26.3 | 1.62% | 0.05% | 1.65% (Dec 2024) | 0% (Oct 2024) | 4.85 k | 3.00 | Mid Cap | 16.59 |
Thermo Fisher Scientific Inc | Foreign equity | 31.1 | 25.5 | 1.56% | -0.02% | 1.95% (Jan 2025) | 1.26% (May 2025) | 591.00 | -4.00 | Other | 54.66 |
# Novo Nordisk A/S | Foreign equity | 31.1 | 24.7 | 1.52% | 0.00% | 0% (Oct 2025) | 0% (Oct 2025) | 5.01 k | 0.00 | Other | 54.66 |
Intuitive Surgical | Foreign equity | 31.1 | 22.3 | 1.37% | -0.07% | 1.74% (Feb 2025) | 1.34% (Oct 2024) | 561.00 | -3.00 | Other | 54.66 |
Ipca Laboratories Ltd. | Pharmaceuticals | 51.39 | 21.6 | 1.33% | -0.04% | 1.68% (Dec 2024) | 1.33% (Sep 2025) | 16.16 k | 10.00 | Other | 54.66 |
Biocon Ltd. | Pharmaceuticals | 51.39 | 21.1 | 1.30% | -0.02% | 1.46% (Jul 2025) | 0.99% (Oct 2024) | 61.93 k | 41.00 | Mid Cap | 16.59 |
Amgen | Foreign equity | 31.1 | 21.1 | 1.29% | -0.02% | 1.42% (Feb 2025) | 1.14% (Dec 2024) | 841.00 | -5.00 | Other | 54.66 |
Gilead Sciences | Foreign equity | 31.1 | 19.2 | 1.18% | -0.01% | 1.22% (Feb 2025) | 0.83% (Oct 2024) | 1.95 k | -19.00 | Other | 54.66 |
Danaher Corporation | Foreign equity | 31.1 | 17.7 | 1.09% | -0.04% | 1.24% (Jan 2025) | 1.01% (May 2025) | 1.01 k | -12.00 | Other | 54.66 |
Stryker Corporation | Foreign equity | 31.1 | 17.7 | 1.09% | -0.05% | 1.15% (Jan 2025) | 0.92% (Oct 2024) | 538.00 | -3.00 | Other | 54.66 |
Gland Pharma Ltd. | Pharmaceuticals | 51.39 | 17.1 | 1.05% | 0.07% | 1.07% (Jul 2025) | 0.77% (Apr 2025) | 8.59 k | 5.00 | Other | 54.66 |
Medtronic Plc | Foreign equity | 31.1 | 16.9 | 1.04% | 0.03% | 1.04% (Sep 2025) | 0.84% (Dec 2024) | 2.00 k | -19.00 | Other | 54.66 |
Narayana Hrudayalaya Ltd. | Hospital | 16.5 | 14.4 | 0.88% | -0.01% | 1.11% (Jun 2025) | 0% (Oct 2024) | 8.28 k | 6.00 | Small Cap | 1.63 |
Vertex Pharmaceuticals | Foreign equity | 31.1 | 14 | 0.86% | 0.01% | 1.06% (Feb 2025) | 0.85% (Dec 2024) | 402.00 | -2.00 | Other | 54.66 |
Piramal Pharma Ltd. | Pharmaceuticals | 51.39 | 13.2 | 0.81% | 0.03% | 1.15% (Dec 2024) | 0% (Oct 2024) | 69.27 k | 228.00 | Other | 54.66 |
- Syngene International Ltd. | Healthcare research, analytics & technology | 0.8 | 13.1 | 0.80% | 0.00% | 1.31% (Nov 2024) | 0.8% (Aug 2025) | 21.00 k | 35.00 | Mid Cap | 16.59 |
GlaxoSmithKline Pharmaceuticals Ltd. | Pharmaceuticals | 51.39 | 13 | 0.80% | -0.04% | 1.07% (May 2025) | 0.62% (Jan 2025) | 4.90 k | 3.00 | Mid Cap | 16.59 |
Global Health Ltd. | Hospital | 16.5 | 12.3 | 0.75% | -0.03% | 0.78% (Aug 2025) | 0.62% (Jan 2025) | 9.33 k | 7.00 | Other | 54.66 |
Ajanta Pharma Limited | Pharmaceuticals | 51.39 | 12.2 | 0.75% | -0.02% | 1.02% (Nov 2024) | 0.75% (Sep 2025) | 5.06 k | 4.00 | Small Cap | 1.63 |
Suven Pharmaceuticals Ltd. | Pharmaceuticals | 51.39 | 11.7 | 0.72% | 0.08% | 1.02% (Nov 2024) | 0.64% (Aug 2025) | 13.29 k | 1.51 k | Other | 54.66 |
Regeneron Pharmaceuticals | Foreign equity | 31.1 | 8.3 | 0.51% | -0.01% | 0.68% (Oct 2024) | 0.43% (May 2025) | 167.00 | -1.00 | Other | 54.66 |
- Becton Dickinson and Co | Foreign equity | 31.1 | 7.5 | 0.46% | 0.00% | 0.61% (Jan 2025) | 0.41% (May 2025) | 448.00 | 0.00 | Other | 54.66 |
Agilent Technologies Inc | Foreign equity | 31.1 | 5.1 | 0.31% | 0.01% | 0.37% (Jan 2025) | 0.24% (Apr 2025) | 445.00 | -2.00 | Other | 54.66 |
- Iqvia Holdings | Foreign equity | 31.1 | 4.6 | 0.28% | 0.00% | 0.31% (Jan 2025) | 0.21% (May 2025) | 271.00 | -6.00 | Other | 54.66 |
- ILLUMINA | Foreign equity | 31.1 | 2.1 | 0.13% | 0.00% | 0.18% (Nov 2024) | 0.1% (Apr 2025) | 247.00 | 0.00 | Other | 54.66 |
Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
---|---|---|---|---|---|---|---|---|
No new entrants in the portfolio in the last month. |
Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
---|---|---|---|---|---|---|---|---|
No complete exits in the portfolio in the last month. |
Stock | Sep 2025 | Aug 2025 | Jul 2025 | Jun 2025 | May 2025 | Apr 2025 | Mar 2025 | Feb 2025 | Jan 2025 | Dec 2024 | Nov 2024 | Oct 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd. | 10.89% | 10.84% | 11.45% | 11.47% | 12.29% | 13.06% | 12.66% | 11.92% | 12.37% | 12.86% | 13.13% | 13.34% | 13.87% |
Max Healthcare Institute Ltd. | 6.17% | 6.36% | 6.77% | 7.08% | 6.68% | 6.34% | 6.39% | 5.93% | 6.10% | 6.23% | 5.85% | 5.95% | 5.88% |
Cipla Ltd. | 6.05% | 6.36% | 6.14% | 6.07% | 5.87% | 6.04% | 5.74% | 5.76% | 5.74% | 5.70% | 6.19% | 6.12% | 6.59% |
Dr. Reddys Laboratories Ltd. | 5.09% | 5.21% | 5.19% | 5.35% | 5.58% | 5.14% | 5.14% | 5.08% | 5.26% | 5.76% | 5.39% | 5.59% | 5.92% |
Divis Laboratories Ltd. | 4.84% | 5.19% | 5.51% | 5.80% | 6.03% | 5.40% | 5.12% | 5.10% | 4.93% | 5.17% | 5.67% | 5.29% | 4.91% |
Apollo Hospitals Enterprises Ltd. | 5.31% | 5.43% | 5.28% | 5.20% | 5.29% | 5.22% | 5.01% | 4.75% | 5.07% | 5.22% | 5.28% | 5.31% | 5.46% |
Lupin Ltd. | 3.11% | 3.06% | 3.08% | 3.16% | 3.41% | 3.55% | 3.58% | 3.39% | 3.51% | 3.82% | 3.59% | 3.75% | 3.80% |
Torrent Pharmaceuticals Ltd. | 3.04% | 2.99% | 3.10% | 2.88% | 2.87% | 2.92% | 2.85% | 2.56% | 2.45% | 2.42% | 2.59% | 2.44% | 2.63% |
Fortis Healthcare Ltd. | 3.39% | 3.17% | 2.94% | 2.78% | 2.65% | 2.50% | 2.46% | 2.34% | 2.32% | 2.51% | 2.49% | 2.30% | 2.26% |
Aurobindo Pharma Ltd. | 2.02% | 1.90% | 2.08% | 2.12% | 2.29% | 2.39% | 2.33% | 2.16% | 2.26% | 2.48% | 2.56% | 2.77% | 2.90% |
Mankind Pharma Ltd. | 2.15% | 2.17% | 2.22% | 2.05% | 2.33% | 2.27% | 2.14% | 2.02% | 1.80% | 2.05% | 1.97% | 2.01% | 1.92% |
Zydus Lifesciences Ltd. | 1.76% | 1.75% | 1.71% | 1.78% | 1.79% | 1.66% | 1.71% | 1.72% | 1.80% | 1.74% | 1.87% | 1.89% | 1.95% |
Glenmark Pharmaceuticals Ltd. | 1.96% | 1.92% | 2.10% | 1.77% | 1.57% | 1.45% | 1.58% | 1.41% | 1.52% | 1.61% | 1.66% | 1.80% | 1.79% |
Laurus Labs Ltd. | 2.10% | 2.13% | 2.14% | 1.81% | 1.63% | 1.57% | 1.60% | 1.44% | 1.51% | 1.50% | 1.53% | 1.29% | 1.24% |
Alkem Laboratories Ltd. | 1.62% | 1.57% | 1.47% | 1.47% | 1.63% | 1.59% | 1.54% | 1.52% | 1.57% | 1.65% | - | - | - |
Name | Type of Instrument | Weight (%) |
---|---|---|
TREPS | TREPS | 0.11% |
Net Receivables | Net Receivables | 0.10% |